Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
53.18B | 51.64B | 50.27B | 48.84B | 47.83B | 45.20B | Gross Profit |
45.68B | 51.64B | 42.75B | 43.00B | 40.80B | 37.93B | EBIT |
38.81B | 39.10B | 39.88B | 39.47B | 38.23B | 35.38B | EBITDA |
42.64B | 42.58B | 43.10B | 41.44B | 40.12B | 35.69B | Net Income Common Stockholders |
28.90B | 28.80B | 28.58B | 27.84B | 27.00B | 24.43B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
117.09B | 140.33B | 174.19B | 179.24B | 187.18B | 197.33B | Total Assets |
467.69B | 466.62B | 442.94B | 415.81B | 396.26B | 372.97B | Total Debt |
30.00B | 30.00B | 30.00B | 30.00B | 30.00B | 30.00B | Net Debt |
-77.57B | -47.65B | -134.96B | -139.02B | -147.65B | -161.59B | Total Liabilities |
243.06B | 241.54B | 237.33B | 230.99B | 230.40B | 227.92B | Stockholders Equity |
224.64B | 225.08B | 205.62B | 184.83B | 165.86B | 145.05B |
Cash Flow | Free Cash Flow | ||||
0.00 | 29.32B | 27.57B | 28.94B | 30.00B | 29.37B | Operating Cash Flow |
0.00 | 31.30B | 28.70B | 29.28B | 30.21B | 29.78B | Investing Cash Flow |
0.00 | -56.00B | -36.04B | -37.95B | -14.32B | 2.71B | Financing Cash Flow |
0.00 | -10.32B | -9.16B | -8.50B | -6.53B | 23.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $3.37T | 10.37 | 12.60% | 2.73% | 2.93% | -8.11% | |
74 Outperform | $1.11T | 11.43 | 21.32% | 4.59% | 6.40% | 28.80% | |
73 Outperform | €433.81B | 13.33 | 13.81% | 3.52% | 4.04% | -0.69% | |
71 Outperform | $2.18T | 9.92 | 11.53% | 3.65% | 30.62% | 8.49% | |
70 Outperform | ¥10.91B | 23.22 | 1.86% | 15.99% | 77.31% | ||
64 Neutral | $12.60B | 9.73 | 7.92% | 16985.68% | 12.21% | -5.61% | |
63 Neutral | ¥15.73B | 44.39 | 0.95% | 0.50% | -12.85% |